{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T07:40:31Z","timestamp":1765525231491,"version":"3.48.0"},"reference-count":66,"publisher":"Walter de Gruyter GmbH","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,10,16]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec id=\"j_dmpt-2025-0011_abs_001\">\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>\n                      Ginger, scientifically known as\n                      <jats:italic>Zingiber officinale<\/jats:italic>\n                      , is a plant root that has a variety of therapeutic applications, including the treatment of nausea, inflammation, digestive problems, and management of renal function in chronic kidney disease (CKD). CKD is a life-threatening condition that, if untreated, leads to organ damage and is acknowledged as a global health concern. The present study aims at predicting bioactive compounds from\n                      <jats:italic>Z.\u00a0officinale<\/jats:italic>\n                      that were identified through gas chromatography-mass spectroscopy (GC-MS), with the potential against a selected target of CKD, and was investigated using a pharmaco-informatics approach.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_dmpt-2025-0011_abs_002\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The compounds from GC-MS analysis were screened, and the structures of identified compounds were drawn through ACD\/Chemsketch 2021.2.1. Based on graph theoretical network analysis, forkhead box protein (FOXO6) was chosen as a potential target for CKD. The Swiss model was used to predict the structure of FOXO6, and the active site details were obtained. Docking was performed against the active sites of FOXO6 using 22 compounds, along with the standard drug, dapagliflozin. Pharmacokinetic, physicochemical and toxicity parameters were predicted for the selected high binders and dapagliflozin. The stability and intermolecular interactions of high binders and dapagliflozin protein-ligand complexes were studied using molecular dynamics simulation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_dmpt-2025-0011_abs_003\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The binding affinity ranges from\u00a0\u22123.5 to\u00a0\u22126.7\u202fkcal\u00a0\u00d7\u00a0mol\n                      <jats:sup>\u22121<\/jats:sup>\n                      . Abietic acid and dehydroabietic acid had a higher binding affinity with a score of\u00a0\u22126.7\u202fkcal\u00a0\u00d7\u00a0mol\n                      <jats:sup>\u22121<\/jats:sup>\n                      , similar to the standard drug, dapagliflozin (\u22126.4\u202fkcal\u00a0\u00d7\u00a0mol\n                      <jats:sup>\u22121<\/jats:sup>\n                      ). Both abietic acid and dehydroabietic acid also have good bioavailability scores. MD simulation studies indicated greater stability for abietic acid-FOXO6 and dehydroabietic acid-FOXO6 complexes.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_dmpt-2025-0011_abs_004\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      This investigation has shed light on the significance of the compounds of\n                      <jats:italic>Z.\u00a0officinale<\/jats:italic>\n                      R. as potential FOXO6 inhibitors, which could further be used as a lead compound for developing alternative therapy for CKD.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1515\/dmpt-2025-0011","type":"journal-article","created":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T13:15:31Z","timestamp":1751462131000},"page":"157-173","source":"Crossref","is-referenced-by-count":0,"title":["Pharmaco-informatics screening of\n                    <i>Zingiber officinale<\/i>\n                    biomolecules targeting FOXO6 for chronic kidney disease therapy"],"prefix":"10.1515","volume":"40","author":[{"given":"Shanmugampillai Jeyarajaguru","family":"Kabilan","sequence":"first","affiliation":[{"name":"Department of Biotechnology , Kalasalingam Academy of Research and Education , Krishnankoil , India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Selvaraj","family":"Kunjiappan","sequence":"additional","affiliation":[{"name":"Department of Biotechnology , Kalasalingam Academy of Research and Education , Krishnankoil , India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Parasuraman","family":"Pavadai","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, Faculty of Pharmacy , M.S. Ramaiah University of Applied Sciences , Bengaluru , India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Murugesan","family":"Sankaranarayanan","sequence":"additional","affiliation":[{"name":"Medicinal Chemistry Research Laboratory, Department of Pharmacy , Birla Institute of Technology and Science Pilani , Pilani , India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krishnan","family":"Sundar","sequence":"additional","affiliation":[{"name":"Department of Biotechnology , Kalasalingam Academy of Research and Education , Krishnankoil , India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"374","published-online":{"date-parts":[[2025,7,3]]},"reference":[{"key":"2025121207015110650_j_dmpt-2025-0011_ref_001","doi-asserted-by":"crossref","unstructured":"Mao, Q-Q, Xu, X-Y, Cao, S-Y, Gan, R-Y, Corke, H, Beta, T, et al.. Bioactive compounds and bioactivities of ginger (Zingiber officinale Roscoe). Foods 2019;8:185. https:\/\/doi.org\/10.3390\/foods8060185.","DOI":"10.3390\/foods8060185"},{"key":"2025121207015110650_j_dmpt-2025-0011_ref_002","doi-asserted-by":"crossref","unstructured":"Romagnani, P, Remuzzi, G, Glassock, R, Levin, A, Jager, KJ, Tonelli, M, et al.. Chronic kidney disease. Nat Rev Dis Primers 2017;3:1\u201324. https:\/\/doi.org\/10.1038\/nrdp.2017.88.","DOI":"10.1038\/nrdp.2017.88"},{"key":"2025121207015110650_j_dmpt-2025-0011_ref_003","doi-asserted-by":"crossref","unstructured":"Cockwell, P, Fisher, L-A. The global burden of chronic kidney disease. Lancet 2020;395:662\u20134. https:\/\/doi.org\/10.1016\/S0140-6736(19)32977-0.","DOI":"10.1016\/S0140-6736(19)32977-0"},{"key":"2025121207015110650_j_dmpt-2025-0011_ref_004","doi-asserted-by":"crossref","unstructured":"Bikbov, B, Purcell, CA, Levey, AS, Smith, M, Abdoli, A, Abebe, M, et al.. Global, regional, and national burden of chronic kidney disease, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 2020;395:709\u201333. https:\/\/doi.org\/10.1016\/S0140-6736(20)30045-3.","DOI":"10.1016\/S0140-6736(20)30045-3"},{"key":"2025121207015110650_j_dmpt-2025-0011_ref_005","doi-asserted-by":"crossref","unstructured":"Thurlow, JS, Joshi, M, Yan, G, Norris, KC, Agodoa, LY, Yuan, CM, et al.. Global epidemiology of end-stage kidney disease and disparities in kidney replacement therapy. Am J Nephrol 2021;52:98\u2013107. https:\/\/doi.org\/10.1159\/000514550.","DOI":"10.1159\/000514550"},{"key":"2025121207015110650_j_dmpt-2025-0011_ref_006","doi-asserted-by":"crossref","unstructured":"Jafar, TH, Ramakrishnan, C, John, O, Tewari, A, Cobb, B, Legido-Quigley, H, et al.. Access to CKD Care in Rural Communities of India: a qualitative study exploring the barriers and potential facilitators. BMC Nephrol 2020;21:1\u201312. https:\/\/doi.org\/10.1186\/s12882-020-1702-6.","DOI":"10.1186\/s12882-020-1702-6"},{"key":"2025121207015110650_j_dmpt-2025-0011_ref_007","doi-asserted-by":"crossref","unstructured":"Martinusen, D, Marin, JG, Cheng, E, Lau, W. Chronic kidney disease and end stage renal disease. In: Ren. Med. Clin. Pharm. Cham, Switzerland: Springer; 2020:45\u2013115 pp.","DOI":"10.1007\/978-3-030-37655-0_4"},{"key":"2025121207015110650_j_dmpt-2025-0011_ref_008","doi-asserted-by":"crossref","unstructured":"James, MT, Hemmelgarn, BR, Wiebe, N, Pannu, N, Manns, BJ, Klarenbach, SW, et al.. Glomerular filtration rate, proteinuria, and the incidence and consequences of acute kidney injury: a cohort study. Lancet 2010;376:2096\u2013103. https:\/\/doi.org\/10.1016\/S0140-6736(10)61271-8.","DOI":"10.1016\/S0140-6736(10)61271-8"},{"key":"2025121207015110650_j_dmpt-2025-0011_ref_009","doi-asserted-by":"crossref","unstructured":"Patel, DM, Bose, M, Cooper, ME. Glucose and blood pressure-dependent pathways\u2013the progression of diabetic kidney disease. Int J Mol Sci 2020;21:2218. https:\/\/doi.org\/10.3390\/ijms21062218.","DOI":"10.3390\/ijms21062218"},{"key":"2025121207015110650_j_dmpt-2025-0011_ref_010","doi-asserted-by":"crossref","unstructured":"Chawla, LS, Kimmel, PL. Acute kidney injury and chronic kidney disease: an integrated clinical syndrome. Kidney Int 2012;82:516\u201324. https:\/\/doi.org\/10.1038\/ki.2012.208.","DOI":"10.1038\/ki.2012.208"},{"key":"2025121207015110650_j_dmpt-2025-0011_ref_011","doi-asserted-by":"crossref","unstructured":"Huang, PP, Shu, DH, Su, Z, Luo, SN, Xu, FF, Lin, F. Association between lifestyle, gender and risk for developing end-stage renal failure in IgA nephropathy: a case-control study within 10 years. Ren Fail 2019;41:914\u201320. https:\/\/doi.org\/10.1080\/0886022X.2019.1635029.","DOI":"10.1080\/0886022X.2019.1635029"},{"key":"2025121207015110650_j_dmpt-2025-0011_ref_012","doi-asserted-by":"crossref","unstructured":"Bello, AK, Alrukhaimi, M, Ashuntantang, GE, Basnet, S, Rotter, RC, Douthat, WG, et al.. Complications of chronic kidney disease: current state, knowledge gaps, and strategy for action. Kidney Int Suppl 2017;7:122\u20139. https:\/\/doi.org\/10.1016\/j.kisu.2017.07.007.","DOI":"10.1016\/j.kisu.2017.07.007"},{"key":"2025121207015110650_j_dmpt-2025-0011_ref_013","doi-asserted-by":"crossref","unstructured":"Chen, TK, Knicely, DH, Grams, ME. Chronic kidney disease diagnosis and management: a review. JAMA 2019;322:1294\u2013304. https:\/\/doi.org\/10.1001\/jama.2019.14745.","DOI":"10.1001\/jama.2019.14745"},{"key":"2025121207015110650_j_dmpt-2025-0011_ref_014","doi-asserted-by":"crossref","unstructured":"Roberti, J, Cummings, A, Myall, M, Harvey, J, Lippiett, K, Hunt, K, et al.. Work of being an adult patient with chronic kidney disease: a systematic review of qualitative studies. BMJ Open 2018;8:e023507. https:\/\/doi.org\/10.1136\/bmjopen-2018-023507.","DOI":"10.1136\/bmjopen-2018-023507"},{"key":"2025121207015110650_j_dmpt-2025-0011_ref_015","unstructured":"Danovitch, GM. Handbook of kidney transplantation. Philadelphia, Pennsylvania, USA: Lippincott Williams & Wilkins; 2012."},{"key":"2025121207015110650_j_dmpt-2025-0011_ref_016","doi-asserted-by":"crossref","unstructured":"Hariharan, S, Israni, AK, Danovitch, G. Long-term survival after kidney transplantation. N Engl J Med 2021;385:729\u201343. https:\/\/doi.org\/10.1056\/NEJMra2014530.","DOI":"10.1056\/NEJMra2014530"},{"key":"2025121207015110650_j_dmpt-2025-0011_ref_017","doi-asserted-by":"crossref","unstructured":"Schrauben, SJ, Apple, BJ, Chang, AR. Modifiable lifestyle behaviors and CKD progression: a narrative review. Kidney360 2022;3:752. https:\/\/doi.org\/10.34067\/KID.0003122021.","DOI":"10.34067\/KID.0003122021"},{"key":"2025121207015110650_j_dmpt-2025-0011_ref_018","doi-asserted-by":"crossref","unstructured":"Qiao, Y, Shin, J-I, Sang, Y, Inker, LA, Secora, A, Luo, S, et al.. Discontinuation of angiotensin converting enzyme inhibitors and angiotensin receptor blockers in chronic kidney disease. In: Mayo Clin Proc. Rochester, MN: Elsevier; 2019, vol 94:2220\u20139 pp.","DOI":"10.1016\/j.mayocp.2019.05.031"},{"key":"2025121207015110650_j_dmpt-2025-0011_ref_019","doi-asserted-by":"crossref","unstructured":"Na Takuathung, M, Sakuludomkan, W, Khatsri, R, Dukaew, N, Kraivisitkul, N, Ahmadmusa, B, et al.. Adverse effects of angiotensin-converting enzyme inhibitors in humans: a systematic review and meta-analysis of 378 randomized controlled trials. Int J Environ Res Publ Health 2022;19:8373. https:\/\/doi.org\/10.3390\/ijerph19148373.","DOI":"10.3390\/ijerph19148373"},{"key":"2025121207015110650_j_dmpt-2025-0011_ref_020","unstructured":"Arumugham, V, Shahin, M. Therapeutic uses of diuretic agents. In: StatPearls. USA: StatPearls; 2023."},{"key":"2025121207015110650_j_dmpt-2025-0011_ref_021","doi-asserted-by":"crossref","unstructured":"Eid, PS, Ibrahim, DA, Zayan, AH, Elrahman, MMA, Shehata, MAA, Kandil, H, et al.. Comparative effects of furosemide and other diuretics in the treatment of heart failure: a systematic review and combined meta-analysis of randomized controlled trials. Heart Failure Rev 2021;26:127\u201336. https:\/\/doi.org\/10.1007\/s10741-020-10003-7.","DOI":"10.1007\/s10741-020-10003-7"},{"key":"2025121207015110650_j_dmpt-2025-0011_ref_022","doi-asserted-by":"crossref","unstructured":"Heerspink, HJL, Stef\u00e1nsson, BV, Correa-Rotter, R, Chertow, GM, Greene, T, Hou, F-F, et al.. Dapagliflozin in patients with chronic kidney disease. N Engl J Med 2020;383:1436\u201346. https:\/\/doi.org\/10.1056\/NEJMoa2024816.","DOI":"10.1056\/NEJMoa2024816"},{"key":"2025121207015110650_j_dmpt-2025-0011_ref_023","doi-asserted-by":"crossref","unstructured":"Chandrashekar, M, Philip, S, Nesbitt, A, Joshi, A, Perera, M. Sodium glucose-linked transport protein 2 inhibitors: an overview of genitourinary and perioperative implications. Int J Urol 2021;28:984\u201390. https:\/\/doi.org\/10.1111\/iju.14624.","DOI":"10.1111\/iju.14624"},{"key":"2025121207015110650_j_dmpt-2025-0011_ref_024","doi-asserted-by":"crossref","unstructured":"Lin, F. Molecular regulation and function of FoxO3 in chronic kidney disease. Curr Opin Nephrol Hypertens 2020;29:439. https:\/\/doi.org\/10.1097\/MNH.0000000000000616.","DOI":"10.1097\/MNH.0000000000000616"},{"key":"2025121207015110650_j_dmpt-2025-0011_ref_025","doi-asserted-by":"crossref","unstructured":"Li, L, Kang, H, Zhang, Q, D\u2019Agati, VD, Al-Awqati, Q, Lin, F. FoxO3 activation in hypoxic tubules prevents chronic kidney disease. J Clin Invest 2019;129:2374\u201389. https:\/\/doi.org\/10.1172\/JCI122256.","DOI":"10.1172\/JCI122256"},{"key":"2025121207015110650_j_dmpt-2025-0011_ref_026","doi-asserted-by":"crossref","unstructured":"Wang, Y, He, W. Improving the dysregulation of FoxO1 activity is a potential therapy for alleviating diabetic kidney disease. Front Pharmacol 2021;12:630617. https:\/\/doi.org\/10.3389\/fphar.2021.630617.","DOI":"10.3389\/fphar.2021.630617"},{"key":"2025121207015110650_j_dmpt-2025-0011_ref_027","doi-asserted-by":"crossref","unstructured":"Miao, C, Li, Y, Zhang, X. The functions of FoxO transcription factors in epithelial wound healing. Australas J Dermatol 2019;60:105\u20139. https:\/\/doi.org\/10.1111\/ajd.12952.","DOI":"10.1111\/ajd.12952"},{"key":"2025121207015110650_j_dmpt-2025-0011_ref_028","doi-asserted-by":"crossref","unstructured":"Khan, MSA, Ahmad, I. Herbal medicine: current trends and future prospects. In: New look to phytomedicine. New York, NY: Elsevier; 2019:3\u201313 pp.","DOI":"10.1016\/B978-0-12-814619-4.00001-X"},{"key":"2025121207015110650_j_dmpt-2025-0011_ref_029","doi-asserted-by":"crossref","unstructured":"Ma, R-H, Ni, Z-J, Zhu, Y-Y, Thakur, K, Zhang, F, Zhang, Y-Y, et al.. A recent update on the multifaceted health benefits associated with ginger and its bioactive components. Food Funct 2021;12:519\u201342. https:\/\/doi.org\/10.1039\/D0FO02834G.","DOI":"10.1039\/D0FO02834G"},{"key":"2025121207015110650_j_dmpt-2025-0011_ref_030","doi-asserted-by":"crossref","unstructured":"Trajkovska-Broach, A, Petkoska, AT. Nutritional values and therapeutical effects of mediterranean herbs, spices, and medicinal plants. In: Herbs spices-new advances. London, UK: IntechOpen; 2022.","DOI":"10.5772\/intechopen.108838"},{"key":"2025121207015110650_j_dmpt-2025-0011_ref_031","doi-asserted-by":"crossref","unstructured":"Yusoff, IM, Taher, ZM, Rahmat, Z, Chua, LS. A review of ultrasound-assisted extraction for plant bioactive compounds: phenolics, flavonoids, thymols, saponins and proteins. Food Res Int 2022;157:111268. https:\/\/doi.org\/10.1016\/j.foodres.2022.111268.","DOI":"10.1016\/j.foodres.2022.111268"},{"key":"2025121207015110650_j_dmpt-2025-0011_ref_032","doi-asserted-by":"crossref","unstructured":"Alseekh, S, Aharoni, A, Brotman, Y, Contrepois, K, D\u2019Auria, J, Ewald, J, et al.. Mass spectrometry-based metabolomics: a guide for annotation, quantification and best reporting practices. Nat Methods 2021;18:747\u201356. https:\/\/doi.org\/10.1038\/s41592-021-01197-1.","DOI":"10.1038\/s41592-021-01197-1"},{"key":"2025121207015110650_j_dmpt-2025-0011_ref_033","doi-asserted-by":"crossref","unstructured":"Rajeshkumar, RR, Kumar, BK, Parasuraman, P, Panneerselvam, T, Sundar, K, Ammunje, DN, et al.. Graph theoretical network analysis, in silico exploration, and validation of bioactive compounds from Cynodon dactylon as potential neuroprotective agents against \u03b1-synuclein. Bioimpacts 2022;12:487\u201399. https:\/\/doi.org\/10.34172\/bi.2022.24113.","DOI":"10.34172\/bi.2022.24113"},{"key":"2025121207015110650_j_dmpt-2025-0011_ref_034","doi-asserted-by":"crossref","unstructured":"Kalimuthu, AK, Panneerselvam, T, Pavadai, P, Pandian, SRK, Sundar, K, Murugesan, S, et al.. Pharmacoinformatics-based investigation of bioactive compounds of rasam (South Indian recipe) against human cancer. Sci Rep 2021;11:1\u201319. https:\/\/doi.org\/10.1038\/s41598-021-01008-9.","DOI":"10.1038\/s41598-021-01008-9"},{"key":"2025121207015110650_j_dmpt-2025-0011_ref_035","doi-asserted-by":"crossref","unstructured":"Shannon, P, Markiel, A, Ozier, O, Baliga, NS, Wang, JT, Ramage, D, et al.. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res 2003;13:2498\u2013504.","DOI":"10.1101\/gr.1239303"},{"key":"2025121207015110650_j_dmpt-2025-0011_ref_036","doi-asserted-by":"crossref","unstructured":"Waterhouse, A, Bertoni, M, Bienert, S, Studer, G, Tauriello, G, Gumienny, R, et al.. SWISS-MODEL: homology modelling of protein structures and complexes. Nucleic Acids Res 2018;46:W296\u2013303. https:\/\/doi.org\/10.1093\/nar\/gky427.","DOI":"10.1093\/nar\/gky427"},{"key":"2025121207015110650_j_dmpt-2025-0011_ref_037","doi-asserted-by":"crossref","unstructured":"Guex, N, Peitsch, MC. SWISS-MODEL and the Swiss-Pdb Viewer: an environment for comparative protein modeling. Electrophoresis 1997;18:2714\u201323. https:\/\/doi.org\/10.1002\/elps.1150181505.","DOI":"10.1002\/elps.1150181505"},{"key":"2025121207015110650_j_dmpt-2025-0011_ref_038","doi-asserted-by":"crossref","unstructured":"Jendele, L, Krivak, R, Skoda, P, Novotny, M, Hoksza, D. PrankWeb: a web server for ligand binding site prediction and visualization. Nucleic Acids Res 2019;47:W345\u20139. https:\/\/doi.org\/10.1093\/nar\/gkz424.","DOI":"10.1093\/nar\/gkz424"},{"key":"2025121207015110650_j_dmpt-2025-0011_ref_039","doi-asserted-by":"crossref","unstructured":"Kabilan, SJ, Kunjiappan, S, Sundar, K, Pavadai, P, Sathishkumar, N, Velayuthaperumal, H. Pharmacoinformatics-based screening of active compounds from vitex negundo against lymphatic filariasis by targeting asparaginyl-tRNA synthetase. J Mol Model 2023;29:87. https:\/\/doi.org\/10.1007\/s00894-023-05488-6. https:\/\/doi.org\/10.1007\/s00894-023-05488-6.","DOI":"10.1007\/s00894-023-05488-6"},{"key":"2025121207015110650_j_dmpt-2025-0011_ref_040","unstructured":"Design, L. Pharmacophore and ligand-based design with Biovia Discovery Studio\u00ae. California: BIOVIA; 2014."},{"key":"2025121207015110650_j_dmpt-2025-0011_ref_041","doi-asserted-by":"crossref","unstructured":"Butina, D, Segall, MD, Frankcombe, K. Predicting ADME properties in\u00a0silico: methods and models. Drug Discov Today 2002;7:S83\u20138. https:\/\/doi.org\/10.1016\/S1359-6446(02)02288-2.","DOI":"10.1016\/S1359-6446(02)02288-2"},{"key":"2025121207015110650_j_dmpt-2025-0011_ref_042","doi-asserted-by":"crossref","unstructured":"Daina, A, Michielin, O, Zoete, V. SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep 2017;7:1\u201313. https:\/\/doi.org\/10.1038\/srep42717.","DOI":"10.1038\/srep42717"},{"key":"2025121207015110650_j_dmpt-2025-0011_ref_043","doi-asserted-by":"crossref","unstructured":"Pires, DEV, Blundell, TL, Ascher, DB. pkCSM: predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures. J Med Chem 2015;58:4066\u201372. https:\/\/doi.org\/10.1021\/acs.jmedchem.5b00104.","DOI":"10.1021\/acs.jmedchem.5b00104"},{"key":"2025121207015110650_j_dmpt-2025-0011_ref_044","unstructured":"Release S. 1. Maestro Desmond interoperability tools. New York, NY, USA: Schr\u00f6dinger; 2020."},{"key":"2025121207015110650_j_dmpt-2025-0011_ref_045","doi-asserted-by":"crossref","unstructured":"Mark, P, Nilsson, L. Structure and dynamics of the TIP3P, SPC, and SPC\/E water models at 298 K. J Phys Chem A 2001;105:9954\u201360. https:\/\/doi.org\/10.1021\/jp003020w.","DOI":"10.1021\/jp003020w"},{"key":"2025121207015110650_j_dmpt-2025-0011_ref_046","doi-asserted-by":"crossref","unstructured":"Jorgensen, WL, Maxwell, DS, Tirado-Rives, J. Development and testing of the OPLS all-atom force field on conformational energetics and properties of organic liquids. J Am Chem Soc 1996;118:11225\u201336. https:\/\/doi.org\/10.1021\/ja9621760.","DOI":"10.1021\/ja9621760"},{"key":"2025121207015110650_j_dmpt-2025-0011_ref_047","doi-asserted-by":"crossref","unstructured":"Tuckerman, M, Berne, BJ, Martyna, GJ. Reversible multiple time scale molecular dynamics. J Chem Phys 1992;97:1990\u20132001. https:\/\/doi.org\/10.1063\/1.463137.","DOI":"10.1063\/1.463137"},{"key":"2025121207015110650_j_dmpt-2025-0011_ref_048","doi-asserted-by":"crossref","unstructured":"Cheng, A, Merz, KM. Application of the Nos\u00e9\u2013Hoover chain algorithm to the study of protein dynamics. J Phys Chem 1996;100:1927\u201337. https:\/\/doi.org\/10.1021\/jp951968y.","DOI":"10.1021\/jp951968y"},{"key":"2025121207015110650_j_dmpt-2025-0011_ref_049","doi-asserted-by":"crossref","unstructured":"Kalibaeva, G, Ferrario, M, Ciccotti, G. Constant pressure-constant temperature molecular dynamics: a correct constrained NPT ensemble using the molecular virial. Mol Phys 2003;101:765\u201378. https:\/\/doi.org\/10.1080\/0026897021000044025.","DOI":"10.1080\/0026897021000044025"},{"key":"2025121207015110650_j_dmpt-2025-0011_ref_050","doi-asserted-by":"crossref","unstructured":"Petchimuthu, P, Ala, C, Kunjiappan, S, Pavadai, P, Sankaranarayanan, M, Ram Kumar Pandian, S, et al.. Pharmacoinformatics-based identification of phytochemicals from Solanum torvum Swartz. fruits as potential inhibitors for MAPK14 protein. J Biomol Struct Dyn 2023:1\u201317. https:\/\/doi.org\/10.1080\/07391102.2023.2246562.","DOI":"10.1080\/07391102.2023.2246562"},{"key":"2025121207015110650_j_dmpt-2025-0011_ref_051","doi-asserted-by":"crossref","unstructured":"Saravanan, G, Panneerselvam, T, Alagarsamy, V, Kunjiappan, S, Parasuraman, P, Murugan, I, et al.. Design, graph theoretical analysis, density functionality theories, Insilico modeling, synthesis, characterization and biological activities of novel thiazole fused quinazolinone derivatives. Drug Dev Res 2018;79:260\u201374. https:\/\/doi.org\/10.1002\/ddr.21460.","DOI":"10.1002\/ddr.21460"},{"key":"2025121207015110650_j_dmpt-2025-0011_ref_052","doi-asserted-by":"crossref","unstructured":"Hamed, MA, Ali, SA, Saba El-Rigal, N. Therapeutic potential of ginger against renal injury induced by carbon tetrachloride in rats. Sci World J 2012;2012. https:\/\/doi.org\/10.1100\/2012\/840421.","DOI":"10.1100\/2012\/840421"},{"key":"2025121207015110650_j_dmpt-2025-0011_ref_053","doi-asserted-by":"crossref","unstructured":"Gabr, SA, Alghadir, AH, Ghoniem, GA. Biological activities of ginger against cadmium-induced renal toxicity. Saudi J Biol Sci 2019;26:382\u20139. https:\/\/doi.org\/10.1016\/j.sjbs.2017.08.008.","DOI":"10.1016\/j.sjbs.2017.08.008"},{"key":"2025121207015110650_j_dmpt-2025-0011_ref_054","doi-asserted-by":"crossref","unstructured":"Rostamkhani, H, Faghfouri, AH, Veisi, P, Rahmani, A, Noshadi, N, Ghoreishi, Z. The protective antioxidant activity of ginger extracts (Zingiber officinale) in acute kidney injury: a systematic review and meta-analysis of animal studies. J Funct Foods 2022;94:105111. https:\/\/doi.org\/10.1016\/j.jff.2022.105111.","DOI":"10.1016\/j.jff.2022.105111"},{"key":"2025121207015110650_j_dmpt-2025-0011_ref_055","unstructured":"Shanmugam, KR, Ramakrishna, CH, Mallikarjuna, K, Reddy, KS. Protective effect of ginger against alcohol-induced renal damage and antioxidant enzymes in male albino rats. Indian J Exp Biol 2010;48:143\u20139."},{"key":"2025121207015110650_j_dmpt-2025-0011_ref_056","doi-asserted-by":"crossref","unstructured":"Cernaro, V, Coppolino, G, Visconti, L, Rivoli, L, Lacquaniti, A, Santoro, D, et al.. Erythropoiesis and chronic kidney disease\u2013related anemia: from physiology to new therapeutic advancements. Med Res Rev 2019;39:427\u201360. https:\/\/doi.org\/10.1002\/med.21527.","DOI":"10.1002\/med.21527"},{"key":"2025121207015110650_j_dmpt-2025-0011_ref_057","doi-asserted-by":"crossref","unstructured":"Yeung, YT, Aziz, F, Guerrero-Castilla, A, Arguelles, S. Signaling pathways in inflammation and anti-inflammatory therapies. Curr Pharm Des 2018;24:1449\u201384. https:\/\/doi.org\/10.2174\/1381612824666180327165604.","DOI":"10.2174\/1381612824666180327165604"},{"key":"2025121207015110650_j_dmpt-2025-0011_ref_058","doi-asserted-by":"crossref","unstructured":"Cao, G, Lin, M, Gu, W, Su, Z, Duan, Y, Song, W, et al.. The rules and regulatory mechanisms of FOXO3 on inflammation, metabolism, cell death and aging in hosts. Life Sci 2023:121877. https:\/\/doi.org\/10.1016\/j.lfs.2023.121877.","DOI":"10.1016\/j.lfs.2023.121877"},{"key":"2025121207015110650_j_dmpt-2025-0011_ref_059","doi-asserted-by":"crossref","unstructured":"Tia, N, Singh, AK, Pandey, P, Azad, CS, Chaudhary, P, Gambhir, IS. Role of Forkhead Box\u00a0O (FOXO) transcription factor in aging and diseases. Gene 2018;648:97\u2013105. https:\/\/doi.org\/10.1016\/j.gene.2018.01.051.","DOI":"10.1016\/j.gene.2018.01.051"},{"key":"2025121207015110650_j_dmpt-2025-0011_ref_060","doi-asserted-by":"crossref","unstructured":"Kim, DH, Lee, B, Lee, J, Kim, ME, Lee, JS, Chung, JH, et al.. FoxO6-mediated IL-1\u03b2 induces hepatic insulin resistance and age-related inflammation via the TF\/PAR2 pathway in aging and diabetic mice. Redox Biol 2019;24:101184. https:\/\/doi.org\/10.1016\/j.redox.2019.101184.","DOI":"10.1016\/j.redox.2019.101184"},{"key":"2025121207015110650_j_dmpt-2025-0011_ref_061","doi-asserted-by":"crossref","unstructured":"Chang, Y-K, Choi, H, Jeong, JY, Na, K-R, Lee, KW, Lim, BJ, et al.. Dapagliflozin, SGLT2 inhibitor, attenuates renal ischemia-reperfusion injury. PLoS One 2016;11:e0158810. https:\/\/doi.org\/10.1371\/journal.pone.0158810.","DOI":"10.1371\/journal.pone.0158810"},{"key":"2025121207015110650_j_dmpt-2025-0011_ref_062","doi-asserted-by":"crossref","unstructured":"Park, HS, Jung, YJ, Lee, D-Y, Moon, KH, Kim, B, Kim, HW. Use of dapagliflozin in patients with advanced diabetic kidney disease. Kidney Res Clin Pract 2018;37:292. https:\/\/doi.org\/10.23876\/j.krcp.2018.37.3.292.","DOI":"10.23876\/j.krcp.2018.37.3.292"},{"key":"2025121207015110650_j_dmpt-2025-0011_ref_063","doi-asserted-by":"crossref","unstructured":"Rognan, D. The impact of in\u00a0silico screening in the discovery of novel and safer drug candidates. Pharmacol Ther 2017;175:47\u201366. https:\/\/doi.org\/10.1016\/j.pharmthera.2017.02.034.","DOI":"10.1016\/j.pharmthera.2017.02.034"},{"key":"2025121207015110650_j_dmpt-2025-0011_ref_064","doi-asserted-by":"crossref","unstructured":"Deng, X, Zhang, S, Wu, J, Sun, X, Shen, Z, Dong, J, et al.. Promotion of mitochondrial biogenesis via activation of AMPK\u2010PGC1\u0251 signaling pathway by ginger (Zingiber officinale Roscoe) extract, and its major active component 6-gingerol. J Food Sci 2019;84:2101\u201311. https:\/\/doi.org\/10.1016\/j.pharmthera.2017.02.034.","DOI":"10.1111\/1750-3841.14723"},{"key":"2025121207015110650_j_dmpt-2025-0011_ref_065","doi-asserted-by":"crossref","unstructured":"Puigserver, P, Rhee, J, Donovan, J, Walkey, CJ, Yoon, JC, Oriente, F, et al.. Insulin-regulated hepatic gluconeogenesis through FOXO1\u2013PGC-1\u03b1 interaction. Nature 2003;423:550\u20135. https:\/\/doi.org\/10.1038\/nature01667.","DOI":"10.1038\/nature01667"},{"key":"2025121207015110650_j_dmpt-2025-0011_ref_066","doi-asserted-by":"crossref","unstructured":"Kenny, PW. Hydrogen-bond donors in drug design. J Med Chem 2022;65:14261\u201375. https:\/\/doi.org\/10.1021\/acs.jmedchem.2c01147.","DOI":"10.1021\/acs.jmedchem.2c01147"}],"container-title":["Drug Metabolism and Personalized Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/dmpt-2025-0011\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/dmpt-2025-0011\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T07:35:32Z","timestamp":1765524932000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/dmpt-2025-0011\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,3]]},"references-count":66,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,7,3]]},"published-print":{"date-parts":[[2025,10,16]]}},"alternative-id":["10.1515\/dmpt-2025-0011"],"URL":"https:\/\/doi.org\/10.1515\/dmpt-2025-0011","relation":{},"ISSN":["2363-8915"],"issn-type":[{"type":"electronic","value":"2363-8915"}],"subject":[],"published":{"date-parts":[[2025,7,3]]}}}